For the Inventor, By the Inventor

Enter assignee name

Bio-mega/boehringer Ingelheim Research Inc.

USPTO Granted Patents = 18

CIPO Patents = 2

Forward Citations = 79

Loading Chart...

Loading Chart...

27 inventors (with patents filed for the assignee):

Pierre Louis Beaulieu (8 out of 45 patents)

Neil Moss (5 out of 34 patents)

Paul C Anderson (5 out of 8 patents)

4. Bruno Simoneau (4 out of 33 patents)

5. Yvan Guindon (3 out of 46 patents)

6. Christiane Yoakim (3 out of 44 patents)

7. Teddy Halmos (3 out of 28 patents)

8. Julian Adams (3 out of 16 patents)

9. Raymond Plante (3 out of 7 patents)

10. Grace L Jung (3 out of 4 patents)

11. Francedillaois Soucy (3 out of 3 patents)

12. Pierre Lavallee (2 out of 8 patents)

13. John DiMaio (2 out of 9 patents)

14. Sumanas Rakhit (2 out of 10 patents)

15. Robert Deziel (2 out of 6 patents)

18 patents: Sort by Forward Citations

1. 5807870 - Substituted pipecolinic acid derivatives as HIV protease inhibitors (1998-09-15),

2. 5672586 - Herpes ribonucleotide reductase inhibitors (1997-09-30),

3. 5648337 - Antiherpes pentapeptides (1997-07-15),

4. 5614533 - Substituted pipecolinic acid derivatives as HIV protease inhibitors (1997-03-25),

5. 5574015 - Isosteric antiherpes peptide derivatives (1996-11-12),

6. 5565476 - N-(hydroxyethyl)butanediamide derivatives (1996-10-15),

7. 5554634 - N-(hydroxyethyl)butanediamide derivatives (1996-09-10),

8. 5552405 - Substituted pyrrolidine derivatives as HIV protease inhibitors (1996-09-03),

9. 5552384 - Antiherpes compositions and method of use (1996-09-03),

10. 5550291 - Process for key intermediates for HIV protease inhibitors (1996-08-27),

11. 5541163 - Renin inhibiting N-(2-amino-2-oxoethyl)butanediamide derivatives (1996-07-30),

12. 5523315 - N-(hydroxyethyl)butanediamide derivatives (1996-06-04),

13. 5502036 - Antiherpes pentapeptide derivatives having a substituted aspartic acid (1996-03-26),

14. 5484771 - Antiherpes peptide derivatives having a 1,4-dioxo-C, N-terminus (1996-01-16),

15. 5476841 - Inhibitors of herpes viral ribonucleotide reductase (1995-12-19),

Bio-mega/Boehringer Ingelheim Research Inc. is a leading pharmaceutical company dedicated to improving the health and quality of life of patients worldwide. With a focus on research and development, they strive to bring innovative medicines to market to address unmet medical needs.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

18 Patents

#4 in Laval

#777 in Canada

#33,129 in the World

Bio-mega/boehringer Ingelheim Research Inc.

Forward Citations = 79

27 inventors:

Pierre Louis Beaulieu (8 out of 45 patents)

Neil Moss (5 out of 34 patents)

Paul C Anderson (5 out of 8 patents)

4. Bruno Simoneau (4 out of 33 patents)

5. Yvan Guindon (3 out of 46 patents)

Please report any incorrect information to support@idiyas.com

Loading…